Clinical Trial

Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 17, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating chronic open wounds.
Protocol Amendment History 1 change
notable Trial sites expanded: 3 -> 14 locations 2026-05-07
Trial Details
NCT Number NCT06918561
Lead Sponsor NuScience Medical Biologics, LLC
Collaborators: SygNola, LLC
Conditions Open Wound
Enrollment 132 participants
Start Date 2025-10-16
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-17